Profitable Companies in the Healthcare Sector to Watch

Wall St. Watchdog generated a special screen for profitable large cap companies in the Capital Goods sector.  The criteria for the screen are:

  • The company trades on an American exchange.  (This includes foreign-domiciled companies whose stocks trade in the form of ADRs on American exchanges.)
  • The company does not trade on the pink sheets.
  • The company is not located in China (Hong Kong is OK).
  • The company’s market capitalization is at least $50 billion
  • Earnings per share based on average diluted shares outstanding over the past 10 years is greater than $0.01.

Following are the companies in the Healthcare sector that meet these criteria:

  • Amgen, Inc. (NASDAQ:AMGN): Its market capitalization is $53,140,000,000. It generated $15,053,000,000 in revenues last fiscal year, which represents a change of 2.81% for the year-over-year period. The stock recently traded at $56.90, its trailing P/E is 11.84, and its current price-to-book ratio is 2.12. Competitors to Watch: Johnson & Johnson (NYSE:JNJ), Novartis AG (NYSE:NVS), Pfizer (NYSE:PFE), GlaxoSmithKline (NYSE:GSK), Biogen (NASDAQ:BIIB), Genzyme (NASDAQ:GENZ), Affymax (NASDAQ:AFFY), Abbott Labs (NYSE:ABT) and Sanofi-Aventis (NYSE:SNY).
  • Abbott Laboratories (NYSE:ABT): Its market capitalization is $82,390,000,000. It generated $35,166,720,000 in revenues last fiscal year, which represents a change of 14.31% for the year-over-year period. The stock recently traded at $53.18, its trailing P/E is 18.43, and its current price-to-book ratio is 3.36. Competitors to Watch: GlaxoSmithKline plc (NYSE:GSK), Pfizer Inc. (NYSE:PFE), Eli Lilly & Co. (NYSE:LLY), Bristol Myers Squibb Co. (NYSE:BMY), Merck & Co., Inc. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), and Sanofi-Aventis (NYSE:SNY).
  • AstraZeneca plc (ADR) (NYSE:AZN): Its market capitalization is $68,200,000,000. It generated $33,269,000,000 in revenues last fiscal year, which represents a change of 1.42% for the year-over-year period. The stock recently traded at $49.65, its trailing P/E is 8.93, and its current price-to-book ratio is 2.94.
  • GlaxoSmithKline plc (ADR) (NYSE:GSK): Its market capitalization is $110,240,000,000. It generated $45,108,953,946 in revenues last fiscal year, which represents a change of 0.08% for the year-over-year period. The stock recently traded at $43.16, its trailing P/E is 38.51, and its current price-to-book ratio is 7.75. Competitors to Watch: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Sanofi-Aventis SA (NYSE:SAN), Abbott Laboratories (NYSE:ABT), Astra Zeneca plc (NYSE:AZN), Roche Holding Ltd. (NYSE:ROG).
  • Johnson + Johnson (NYSE:JNJ): Its market capitalization is $184,010,000,000. It generated $61,587,000,000 in revenues last fiscal year, which represents a change of -0.50% for the year-over-year period. The stock recently traded at $67.27, its trailing P/E is 15.25, and its current price-to-book ratio is 3.08. Competitors to Watch: GlaxoSmithKline plc (NYSE:GSK), Pfizer Inc. (NYSE:PFE), Bristol Myers Squibb Co. (NYSE:BMY), Merck & Co., Inc. (NYSE:MRK), Abbott Laboratories (NYSE:ABT), Boston Scientific Corporation (NYSE:BSX), Eli Lilly & Co. (NYSE:LLY), and Amgen, Inc. (NASDAQ:AMGN).
  • Novo Nordisk A/S (ADR) (NYSE:NVO): This company operates in the Healthcare sector. Its market capitalization is $69,630,000,000. It generated $11,618,314,296 in revenues last fiscal year, which represents a change of 18.99% for the year-over-year period. The stock recently traded at $126.13, its trailing P/E is 25.43, and its current price-to-book ratio is 8.95.
  • Novartis AG (ADR) (NYSE:NVS): This company operates in the Healthcare sector. Its market capitalization is $140,160,000,000. It generated $51,561,000,000 in revenues last fiscal year, which represents a change of 14.32% for the year-over-year period. The stock recently traded at $61.47, its trailing P/E is 14.71, and its current price-to-book ratio is 2.59.
  • Pfizer Inc. (NYSE:PFE): This company operates in the Healthcare sector. Its market capitalization is $158,850,000,000. It generated $67,809,000,000 in revenues last fiscal year, which represents a change of 35.59% for the year-over-year period. The stock recently traded at $20.04, its trailing P/E is 19.09, and its current price-to-book ratio is 1.76. Competitors to Watch: Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK), GlaxoSmithKline plc (NYSE:GSK), Bristol Myers Squibb Co. (NYSE:BMY), Eli Lilly & Co. (NYSE:LLY), Abbott Laboratories (NYSE:ABT), Novartis AG (NYSE:NVS), Mylan Inc. (NASDAQ:MYL), Amgen, Inc. (NASDAQ:AMGN), and Sanofi-Aventis SA (NYSE:SNY)

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!

More from The Cheat Sheet